Alector Inc
ALEC
NASDAQ
Biotechnology
$1.96
USD
-0.08 (-3.92%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $227.22M
Volume 596.4K
Revenue
$18.42M
TTM
-79.2%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-125.39M
TTM
-1.6%
YoY
Operating Cash Flow
$-173.06M
TTM
+24.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 3.7 | 7.9 | 3.3 | 6.2 | 1.0 |
YoY Growth | -76.9% | -47.8% | -78.8% | -88.5% | -71.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 3.7 | 7.9 | 3.3 | 6.2 | 1.0 |
Selling, General & Administrative | 14.7 | 14.4 | 11.5 | 13.3 | 8.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 48.4 | 42.0 | 40.9 | 45.8 | 26.0 |
Operating Income | -44.7 | -34.1 | -37.6 | -39.6 | -24.9 |
EBITDA | -43.7 | -31.8 | -36.4 | -38.4 | -23.8 |
Other Income / Expense | 4.2 | 3.6 | 2.9 | 2.5 | 2.0 |
Total Other Income / Expense | 4.2 | 3.6 | 2.9 | 2.5 | 2.0 |
Income Before Income Taxes | -40.5 | -30.5 | -34.7 | -37.1 | -22.9 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 |
Net Income | -40.5 | -30.5 | -34.7 | -37.3 | -22.9 |
Consolidated Net Income / Loss | -40.5 | -30.5 | -34.7 | -37.3 | -22.9 |
Net Income Attributable to Common Shareholders | -40.5 | -30.5 | -34.7 | -37.3 | -23.2 |
Basic EPS | -$0.41 | -$0.30 | -$0.34 | -$0.34 | -$0.21 |
Diluted EPS | -$0.41 | -$0.30 | -$0.34 | -$0.34 | -$0.21 |
Basic Shares Outstanding | 99.4M | 100.4M | 102.6M | 109.6M | 110.6M |
Diluted Shares Outstanding | 99.4M | 100.4M | 102.6M | 109.6M | 110.6M |